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Abstract 
This paper describes the development of an electrochemical assay based on screen-printed 
carbon sensors for the determination of clonazepam in serum and in wine.  The cyclic 
voltammetric behaviour of the drug was investigated and the effects of pH and scan rate on 
the peak current and peak potential determined.  Two reduction peaks were recorded on 
the initial negative going scan, which were considered to result from the 2e-, 2H+ reduction 
of the 4,5-azomethine and from the 4e-, 4H+ reduction of the 7-NO2 to a hydroxylamine.  On 
the return positive going scan an oxidation peak was seen, which was considered to result 
from the 2e-, 2H+ oxidation (O1) of the hydroxylamine to the corresponding nitroso species.  
At pH 11 the solution of clonazepam was found to turn from clear to yellow in colour and 
the voltammetric signal of the O1 oxidation process was found to be adsorptive in nature, 
this was exploited in the development of an adsorptive stripping voltammetric assay.  
Experimental conditions were then optimised for the differential pulse adsorptive 
voltammetric measurement of clonazepam in wine and serum samples.  It was shown that 
these analyses could be performed on only 100 µL of sample which was deposited on the 
sensor surface.  Mean recoveries of 79.53 % (%CV = 9.88 %) and 88.22 % (%CV = 14.1 %) 
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were calculated for wine fortified with 3.16 µg/mL and serum fortified with 12.6 µg/mL 
respectively.  
 
Keywords: clonazepam, beverages, cyclic voltammetry, adsorptive stripping voltammetry, 
electrochemical sensor, screen-printed. 
1. Introduction 
Since the introduction of Librium® in 1960 [1], a large number of structurally similar 
benzodiazepine compounds have been developed and utilised widely as tranquillisers, 
anticonvulsants, amnestics, hypnotics, sedatives anxiolytics, [2] .  They were originally 
regarded being safer than older drugs such as barbiturates, but still as effective.  However, 
issues have emerged, such as dependence and withdrawal problems [3-5], and side-effects 
such as dizziness leading to injuries and falls in the elderly [6].  Benzodiazepines are often 
abused by poly-drug abusers to lengthen the "high" generated by other drugs and lessen the 
withdrawal problems [7-9].  Reports have highlighted their use in drug-facilitated crime 
(DFC), drug-facilitated sexual assaults (DFSA) [10-12].  Detectable levels have also been 
recently reported in potable and environmental water systems, resulting in possible toxic 
effects for both humans and aquatic life [13-15].   
Clonazepam (5-(2-chlorophenyl)-7-nitro-2,3-dihydro-1,4-benzodiazepin-2-one, i) has been 
identified as one of the more common benzodiazepines that has been used illegally [16,17] 
and has been reported in cases of sexual assault [18].  It is one of the more potent 1,4-
benzodiazepines and is prescribed for the treatment of a wide range of afflictions such as 
sleep disturbance, depression [19], anxiety and panic disorders [20], forms of parasomnia 
[21], obsessive–compulsive disorder [22], seizures [23], certain types of migraines [24] and 
epilepsy [25].  
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Studies have shown that it is possible to electrochemically determine clonazepam using a 
variety of different working electrode materials.  Clonazepam, amongst a number of other 
benzodiazepines, including: flurazepam, alprazolam, midazolam, medazepam, 
chlordiazepoxide, and diazepam have detected in phytotherapeutic formulations at a Hg 
drop electrode exhibiting a linear range of 1.0 x 10-6 to 30.0 x10-6 M when utilising pH 10 
Ringer solution as the supporting electrolyte [26].  The benzodiazepines determine were 
divided into four separate groups according to their cathodic voltammetric behaviour 
allowing for the rapid voltammetric scanning of these formulations. 
Recently, Martins et al [27] have reported on the determination of clonazepam, diazepam, 
flunitrazepam and nitrazepam at a boron doped diamond electrode (BDDE), as part of a 
liquid chromatographic system.  Cyclic voltammetry was utilised to investigate the 
electrochemical behaviour of the four benzodiazepines at the BDDE in 0.1 M phosphate 
buffer at pH 3.5, 6.0 and 8.0 with the optimum response obtained at pH 3.5.  
Chromatographic separation was achieved at octyldecyl stationary phase utilising a mobile 
phase of sodium phosphate (pH 3.5; 0.10 M) acetonitrile (65:35, v/v), with a flow rate of 1.2 
ml/min.  A thin layer amperometric detector operated in the pulse mode was used for the 
detection of the benzodiazepines.  The optimum wave form for the reduction was reported 
to be -1.9 V, +1.5 V and -0.5 V, with repetition time of 0.5 s.  Detection limits of 0.5, 0.6 and 
2.0 µg/ml were reported for nitrazepam, clonazepam and diazepam respectively.  Analysis 
of pharmaceutical tablet formulations showed good agreement with that found by liquid 
chromatography with UV diode array detection. 
Previously, we have determined a variety of benzodiazepines using both screen-printed 
carbon electrodes (SPCEs) [28,29].  Consequently, we considered that it should be feasible 
to develop an electrochemical for the determination of clonazepam, using a SPCE.   
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In this paper we first discuss the cyclic voltammetric behaviour of clonazepam; we then 
describe the optimisation of the conditions for an adsorptive stripping voltammetric (AdSV) 
based assay for its quantification in beverages and serum.  To our knowledge this is the first 
report on the redox behaviour of clonazepam using a SPCE and its electroanalytical 
exploitation. 
2. Experimental  
2.1 Chemicals and Reagents 
All chemicals were obtained from Fisher (Loughborough, UK), unless otherwise stated.  
Deionized water was obtained from a Purite RO200 – Stillplus HP System, (Purite Oxon., UK).  
Solutions of disodium, trisodium, sodium o-phosphate and o-phosphoric acid were made at 
a concentration of 200 mM by dissolving the appropriate mass in deionized water.  These 
were then titrated together, to give the desired pH.  A stock solution of clonazepam (Sigma-
Aldrich, Dorset, UK) was prepared by dissolving the required mass in ethanol to give a 
concentration of 10 mM.  Working standards, for initial voltammetric studies, were 
prepared daily by dilution of this solution with phosphate buffer to give a final 
concentration of 100 mM phosphate buffer containing 1 mM clonazepam.  These were then 
adjusted with sufficient water to give a 10 % ethanol solution.  A white wine beverage 
sample (Mannara, Grillo Pinot Grigio, Sicilia, 2008, 13 % v/v) was obtained from a local 
commercial outlet.  Foetal bovine serum was obtained from Biosera (Brambleside, UK). 
2.2 Apparatus and Instrumentation 
Cyclic and differential pulse voltammetry were performed with a Pstat10 potentiostat 
interfaced to a PC for data acquisition via the General Purpose Electrochemical System 
Software Package (GPES) version 3.4 (Autolab, Windsor Scientific Limited, Slough, Berkshire, 
UK).  The C10903P14 ink based SPCEs were supplied by Gwent Electronic Materials Ltd 
5 
 
(Pontypool, UK).  The design of which has been shown elsewhere [30].  Initial studies were 
performed using a 10 mL voltammetric cell (Metrohm, Switzerland).   
2.3 Electrochemical Conditions 
Cyclic voltammograms were initially recorded with plain solutions of 0.1 M phosphate 
buffer, containing 10 % ethanol and then in the same solution containing 1 mM clonazepam.  
Samples were purged with nitrogen (BOC, Guildford, UK) for 10 minutes to eliminate 
oxygen.  A starting potential of 0.0 V, an initial switching potential -1.7 V, second switching 
potential +1.0 V and end potential of 0.0 V were utilized.  A new SPCE was used for each 
determination.  Differential pulse voltammetry was undertaken using a starting potential 
of -1.5 V (held for 60 s) and a final potential of 0.0 V; using a step height of 10 mV, pulse 
repetition time 0.2 s, pulse amplitude of 100 mV, and pulse duration of 50 ms.   
2.4 Evaluation of the Adsorptive Stripping Voltammetric Assay 
2.4.1 Determination of Clonazepam in Wine 
A 25 mL aliquot of wine fortified with 3.16 µg/mL of clonazepam was treated with 1.9 g of 
trisodium phosphate to produce a concentration of 0.2 M of this salt.  A 5 mL aliquot of this 
mixture was diluted with sufficient water and ethanol to give a 0.1 M phosphate/10 % 
ethanol solution taking into consideration the original ethanol concentration of the wine.  A 
100 µL aliquot of this solution was examined directly on the strip using the optimised 
DPAdSV conditions.  The concentration of clonazepam was determined using the method of 
multiple standard additions.  A total of six repeat samples were analysed and the recovery 
and precision were calculated. 
2.4.2 Determination of Clonazepam in Serum 
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A 2 mL aliquot of serum was fortified with 12.6 µg/mL of clonazepam and was extracted 
with an equal volume of ethyl acetate by shaking by hand for 3 minutes.  The two phases 
were allowed to separate and 1 mL of the resulting organic layer was taken and blown down 
to dryness under nitrogen at room temperature.  This residue was then reconstituted in 0.5 
mL of the optimised supporting electrolyte (0.1 M pH 11 phosphate buffer containing 10% 
ethanol).  Aliquots of 100 µL were then taken and pipetted to the screen-printed sensor 
surface and examined using the optimised DPAdSV conditions.  The concentration of 
clonazepam present was determined using the method of multiple standard addition.  A 
total of five repeat samples were analysed and the recovery and precision were calculated. 
3. Results and Discussion 
3.1 Cyclic Voltammetric Behaviour 
Figure 1(A) shows a typical cyclic voltammogram obtained with clonazepam at pH 7 using a 
SPCE.  R1 is believed to result from the 4e-, 4H+ reduction of the 7-nitro group to a 
hydroxylamine with an associated loss of water (eq.1).  The subsequent R2 process results 
from the 2e-, 2H+ reduction of the 4,5-azomethine group (eq.2).  On the return positive scan 
an oxidation peak (O1) is obtained, resulting from the oxidation of the hydroxylamine to 
produce a nitroso species (eq.3).  This mechanism is in agreement with that suggested 
recently reported by Lu et al [31].  In our study, two other oxidation peaks were obtained, 
which probably result from the oxidation of the 1-N and 4-N lone electrode pairs to form 
radical species. 
R-NO2   +   4e
-   +   4H+    →   R-N(H)OH   +   H2O   (eq.1) 
R-C=N-R’   +   2e-   +   2H+   →   R-C(H)-N(H)-R’   (eq.2) 
R-N(H)OH   →   R-N=O   +   2e-   +   2H+       (eq.3) 
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When the solution was adjusted to pH 11.0 the solution was observed to turn from 
colourless to yellow.  Cyclic voltammetric investigations of clonazepam at this pH showed 
similar behaviour to that seen at lower pH values (figure 1B); however, the reduction peak 
R2 is absent.  This we believe is due to base hydrolysis of the 4,5-azomethine bond resulting 
in ring opening and consequently loss of this electroactive functional group.  Previous 
studies of clonazepam have shown that the drug is unstable at both high and low pH 
producing several degradation products [32,33]; these were reported to be carbostyril and 
2-amino-2’-chloro-5-nitrobenzophenone [33].   
Previous studies of aromatic primary amines [34] have shown their voltammetric oxidation 
potentials (+0.8 V to +1.0 V) to be much higher than that of the hydroxylamine studied in 
this investigation.  Consequently, we do not believe that the principal biological metabolite, 
7-amino-clonazepam would interfere with our determination of clonazepam. 
3.2 Effect of pH and Scan Rate 
At each pH value investigated we explored the effect of scan rate (v), over the range 20 to 
200 mV/s, on the cyclic voltammetric behaviour of clonazepam.  The peak potentials for 
both reduction peaks, R1 and R2 were found to be linearly dependent with pH.  A plot of Ep 
vs. pH between pH 3 and 9 produced a slope of 50 mV/pH, close to the theoretical value 
expected for a reduction process involving an equal number of protons and electrons.  
However, at higher pH values Ep values for both peaks were not found to follow the 
predicted slope and were considered to result from the reduction of a base hydrolysis 
product rather than clonazepam itself.   
The Ep vs. pH plot for the oxidation peak O1 was found to give a slope of 60 mV/pH, 
indicative of an oxidation process involving an equal number of protons and electrons.  The 
effect of scan rate on the magnitude of ip was examined over the pH range 3 – 11.  The 
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current function vs. pH was plotted for each pH value and the plot obtained with pH 11 is 
shown in figure 2.  Clearly this exhibited a positive slope which indicates reactant adsorption 
at the SPCE surface.  This adsorptive behaviour is very attractive analytically as it may be 
exploited to enhance sensitivity by developing an adsorptive stripping voltammetric assay 
for clonazepam.  Consequently, further investigations were undertaken to explore this 
possibility.   
3.3 Effect of Accumulation Potential  
Figure 3 shows the effect of accumulation potential on the result peak current (ip) 
magnitude of O1 obtained by differential pulse voltammetry using an accumulation time of 
60 s using an 80 µM clonazepam solution.  A near linear relationship with applied potential 
was gained between -0.9 and -1.5 V (vs. Ag/AgCl) followed by a plateau.  Further studies 
were made using an applied potential of -1.5 V (vs. Ag/AgCl).   
3.4 Effect of Accumulation Time 
Figure 4 shows the effect of increasing accumulation time at an applied potential of -1.5 V 
for the same differential pulse voltammetric conditions and concentration as above.  The 
resulting oxidation stripping peak was found to increase with time until 240 s.  In order to 
avoid complete monolayer of the SPCE surface which would result in unreliable data we 
chose an accumulation time of 60 s for further studies. 
3.5 Effect of Sample Volume 
In previous studies we have shown that it was possible to use µL sample volumes for the 
determination of other benzodiazepines [28] and nitroaromatics compounds [35].  As it was 
our goal to apply these devices in the area of bioanalysis and forensic investigations, where 
the collection of large sample volumes can be problematic, we investigated the possibility of 
using a similar approach.  Consequently, to investigate the possibility of using such a system 
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the effect of dissolved oxygen in solution, and sample size on the anodic peak (O1) was 
examined.  It was found possible to use non-degassed samples of only 100 µL which could 
be deposited directly onto the surface of the SPCE, ensuring both the working and pseudo-
reference/counter electrodes were covered.  The small sample size and the presence of 
oxygen, had no effect on the voltammetric response, therefore, in further studies sample 
volumes of 100 µL were used. 
3.6 Calibration curve and limit of detection 
At this point we decided to use the more sensitive differential pulse waveform [29] for 
quantitative measurements of clonazepam.  Initial studies were undertaken to study the 
effect of clonazepam concentrations on the magnitude of the differential pulse adsorptive 
stripping peak O1 occurring at a potential of -0.6 V.  The calibration plot was linear over the 
range 2.05 – 8.00 µg/mL (R2 = 0.984), with a sensitivity of 21.8 nA/µg/mL; above this 
concentration the response was found to show curvature as a monolayer is approached.  
The theoretical detection limit, defined as three times the mean baseline noise was 
calculated to be 1.96 µg/mL.  A coefficient of variation of 7.4 % was obtained for a 7.1 mg/L 
solution of clonazepam. 
4. Analytical Application 
4.1 Determination of Clonazepam in Wine 
The proposed screen-printed carbon sensors were evaluated by carrying out clonazepam 
determinations on white wine (Mannara, Grillo Pinot Grigio, Sicilia, 2008, 13 % v/v) before 
and after spiking with clonazepam at a concentration of 3.16 µg/mL.  The deposition time 
and potential, as well as DPAdSV parameters were the same as used previously.  The 
concentration of clonazepam was determined using the method of multiple standard 
additions and Figure 5 shows the effect of added standards to a typical white wine sample.  
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Table 1 shows the precision and recovery data that we obtained on the wine samples.  
These data demonstrate that the proposed method has promise for the determination of 
clonazepam in such samples. 
4.2 Determination of Clonazepam in Serum 
Serum samples were first extracted with ethyl acetate and then reconstituted in the 
optimised supporting electrolyte.  These were then measured in the same manner as 
described for the white wine samples (figure 6).  The precision and recovery data obtained 
for a serum sample spiked with 12.6 µg/mL is shown in table 2.  This concentration of drug 
could arise as a result of accidental or deliberate overdose; consequently, our adsorptive 
stripping voltammetric assay would be applicable to identifying and quantifying the drug for 
such situations. 
5. Conclusions 
A simple and rapid method for the determination of clonazepam in wine and serum samples 
by DPAdSV in conjunction with SPCE sensors has been successfully developed.  Using an 
applied potential of -1.5 V for 60 s, concentrations as low as 2.0 mg/L could be readily be 
determined in white wine and serum.  A theoretical detection limit of 1.96 µg/mL was found 
which is an improvement on that reported by Latorre et al [36] at a glassy carbon electrode.  
Previous polarographic studies have demonstrated lower limits of detection, but have 
required the use of Hg working electrodes [37,38].  More recent reports have utilised 
modifications of the working electrode surface such as with silver nanoparticle/multi walled 
carbon nanotube nanocomposites [39].  However, we do not feel that this approach will 
allow for mass production that has been shown by screen-printing [40,41]. The proposed 
method gives reliable results using the standard addition method. In future studies we will 
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investigate the possibility of using this technique to determine other drugs and nitro 
compounds. 
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White Wine 
    
Original concentration 
(µg/mL) 
Fortified Concentration 
(µg/mL) Detected Concentration (µg/mL) 
Recovery 
(%) 
ND 3.16 2.44 77.4 
ND 3.16 2.67 84.6 
ND 3.16 2.62 82.9 
ND 3.16 2.66 84.4 
ND 3.16 2.45 77.7 
ND 3.16 2.87 90.9 
ND 3.16 2.66 84.4 
   Mean 83.2 
   Standard Deviation 4.62 
   Coefficient of Variation 5.6 
 
Table 1. Recovery and precision data for clonazepam obtained on white wine samples, ND = not 
detected. 
 
 
Serum 
   Fortified Concentration 
(µg/mL) Detected Concentration (µg/mL) 
Recovery 
(%) 
ND 12.63 11.38 90.1 
ND 12.63 9.69 76.7 
ND 12.63 9.17 72.6 
ND 12.63 13.50 106.9 
ND 12.63 11.97 94.8 
 
 
Mean 88.2 
 
 
Standard Deviation 13.9 
 
 
Coefficient of Variation 15.8 
 
Table 2. Recovery and precision data for clonazepam obtained on bovine serum samples, ND = not 
detected. 
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Figure 1. Cyclic voltammogram obtained using a scan rate of 50 mV/s with 10 % ethanol, 0.1 M phosphate at (A) pH 7.0 and (B) pH 11, dashed line in the 
absence of and solid line in the presence of 1 mM clonazepam.  Voltammetric conditions: starting potential 0.0 V, initial switching,  1.7 V and second 
switching potential +1.0 V. 
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Figure 2.  Current function plot for pH 11 O1 peak. 
 
 
 
 
 
Figure 3. Effect of accumulation potential on 0.1 mM clonazepam O1 oxidation peak obtained by 
linear sweep voltammetry at pH 11.  A new SPCE was used for each determination. 
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Figure 4. Effect of accumulation time on 0.1 mM clonazepam O1 oxidation peak obtained by linear 
sweep voltammetry at pH 11.  A new SPCE was used for each determination. 
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Figure 5. Adsorptive stripping voltammetry of white wine fortified with 3.16 µg/mL clonazepam. 
Standard addition of (i) 0 µM (ii) 10 µM, (iii) 20 µM and (iv) 30 µM. Conditions: -1.5 V for 60 s, 100 µL 
sample volume.  A new SPCE was used for each determination. 
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Figure 6. Adsorptive stripping voltammetry of serum fortified with 12.63 µg/mL clonazepam. 
Standard addition of (i) 0 µg/mL (ii) 3.16 µg/mL, (iii) 6.31 µg/mL and (iv) 9.47 µg/mL. Conditions: -1.5 
V for 60 s, 100 µL sample volume.  A new SPCE was used for each determination. 
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